NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/03/2026
Voltar para busca
Dado oficial do USPTO
TESORAI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
17/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
08/02/2023
Data de registro
17/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/03/2026
Última transação
17/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
02/06/2024
Primeiro uso no comércio
02/06/2024
Código do desenho
4
Tipo de titular
03
Localização do titular
SAN DIEGO, CA, US
Examinador
FLOWERS, JAY K
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
TESORAI, INC.
Miao, Melissa
Representantes
Trevor A. Caudle, Esq. TREVOR CAUDLE LAW PRACTICE, PC
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services as well as research and design services relating theretoresearch services to support pharmaceutical and biotech research and clinical development; Industrial analysis and research servicesmass spectrometry services and life sciences research services; Scientific research; Preclinical development of therapeutic products; Design and development of software; Laboratory testing; Chemical and biological laboratory services; Consultancy relating to laboratory testing; Data analytics services in the life sciences industryraw data preprocessing via artificial intelligence-enabled pipelines that preprocess mass spectrometry and sequencing data in the fields of proteomicsgenomicsepigenomicstranscriptomicschemoproteomicsmetabolomicssystems biologyflow cytometrystructural biologyimaging data; Data filtering and ranking services in the life sciences industrythe development of algorithms to optimize ranking of interactions and hits from mass spectrometry and sequencing data in the fields of proteomicsgenomicsepigenomicstranscriptomicschemoproteomicsmetabolomicssystems biologyflow cytometrystructural biologyimaging data; Development of computational models in the life sciences industry that predict interactions from mass spectrometry and sequencing data in the fields of proteomicsgenomicsepigenomicstranscriptomicschemoproteomicsmetabolomicssystems biologyflow cytometrystructural biologyimaging data; Development of analytical approaches to generate novel biology and disease insights both from models and data in the fields of proteomicsgenomicsepigenomicstranscriptomicschemoproteomicsmetabolomicssystems biologyflow cytometrystructural biologyimaging data; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for research services to support pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for data analyticsdata preprocessingdata filtering and rankingall of which in the fields of pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software that allows users to viewmanipulateanalyze datainformation and reports in the fields of pharmaceutical and biotech research and drug development
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
24/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
20/02/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/02/2026
IUAF
USE AMENDMENT FILED
13/08/2025
EISU
TEAS STATEMENT OF USE RECEIVED
13/08/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/03/2025
EX1G
SOU EXTENSION 1 GRANTED
10/03/2025
EXT1
SOU EXTENSION 1 FILED
10/03/2025
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2024
PUBO
PUBLISHED FOR OPPOSITION
16/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/04/2024
GNRT
NON-FINAL ACTION E-MAILED
29/04/2024
CNRT
NON-FINAL ACTION WRITTEN
29/04/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
24/04/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/11/2023
GNRT
NON-FINAL ACTION E-MAILED
14/11/2023
CNRT
NON-FINAL ACTION WRITTEN
14/11/2023
DOCK
ASSIGNED TO EXAMINER
06/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/02/2023
NWAP
NEW APPLICATION ENTERED
11/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TESORAI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.